Document the dates you worked on your project. This should be a detailed account of the work done each day for your project.
2024 | mRNA | LNP's | Cell Line Experiments | |||
---|---|---|---|---|---|---|
May | PCR | Ion. Lipids | ||||
June | PCR | |||||
July |
|
|||||
Aug. |
|
Yeast mRNA | ||||
Sept. | Purification |
|
HEK |
Time: xx:xx xx/xx/xx
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Tristique sollicitudin nibh sit amet commodo nulla facilisi nullam. Ornare lectus sit amet est placerat in egestas erat imperdiet. At urna condimentum mattis pellentesque id nibh tortor id. Sed viverra tellus in hac habitasse platea dictumst vestibulum. Aliquam vestibulum morbi blandit cursus risus at ultrices mi tempus. Purus gravida quis blandit turpis cursus in. Euismod lacinia at quis risus sed vulputate. Dignissim convallis aenean et tortor at risus viverra adipiscing at. Eget sit amet tellus cras adipiscing enim eu turpis. Amet commodo nulla facilisi nullam vehicula ipsum a arcu. Consequat semper viverra nam libero. Pretium vulputate sapien nec sagittis. Ullamcorper dignissim cras tincidunt lobortis feugiat vivamus. Accumsan sit amet nulla facilisi morbi tempus iaculis urna. Diam maecenas sed enim ut sem viverra aliquet eget. Malesuada proin libero nunc consequat interdum. Pharetra massa massa ultricies mi quis hendrerit dolor magna. Euismod elementum nisi quis eleifend quam adipiscing vitae proin sagittis. Blandit cursus risus at ultrices. Dui sapien eget mi proin sed libero enim sed. Nisl suscipit adipiscing bibendum est ultricies integer. Sapien pellentesque habitant morbi tristique senectus et netus et malesuada. Arcu vitae elementum curabitur vitae nunc sed. Volutpat sed cras ornare arcu dui vivamus arcu felis. Sed risus ultricies tristique nulla aliquet enim tortor. Felis eget nunc lobortis mattis aliquam faucibus. Feugiat nisl pretium fusce id velit ut. Ut tortor pretium viverra suspendisse potenti nullam ac tortor vitae. Morbi tristique senectus et netus et malesuada fames ac turpis. Duis at tellus at urna condimentum mattis pellentesque id nibh. Sed velit dignissim sodales ut eu sem. At ultrices mi tempus imperdiet nulla malesuada pellentesque elit. Molestie ac feugiat sed lectus vestibulum mattis ullamcorper velit sed. Dis parturient montes nascetur ridiculus mus mauris. Ornare lectus sit amet est placerat in egestas. Nunc faucibus a pellentesque sit amet. Scelerisque varius morbi enim nunc faucibus a pellentesque sit amet. Neque ornare aenean euismod elementum nisi quis eleifend quam adipiscing.
Name of Notebook Task/Page
01/01/1970 - 21/12/12
Title 1Background: Hmm.. You're not supposed to be seeing this.. |
1st Jan 1970 Example loaded inParticipants:
Protocols:
Experimental:Procedure:
|
2nd Jan 1970 Example getting removedParticipants:
Protocols:
Experimental:Procedure:
|
DNA Amplification via PCR
16/05/24 - 04/07/24
RAD101: New pcr with forward primer (T7 terminator) and reverse primer (F8 primer) with gel electrophoresis and its extraction. | |||||||||||||||||||||
16th of May 2024 Participants:
Experimental:(1st part) First PCR:
| |||||||||||||||||||||
24th of May 2024 Participants:
Experimental:(2nd part) gel electrophoresis:
| |||||||||||||||||||||
3rd of June 2024 Participants:
Experimental:(3rd part) DNA extraction from gel:
Results and Discussion:Figure 1. Gel, 24/05/24 We can see little smears and some nice bands, it’s not perfect but based on these results we decided to extract the DNA out of the gel and amplify it in order to get a lot of ‘pure’ factor 8 DNA. Figure 2. 1st DNA ladder, 2nd negative control, 3rd positive, 4th PCR reaction with new primers (RAD102), 5th eluted DNA, 6st another DNA ladder. 03/06/24 The purified DNA gives a clear band at the expected height, but the concentration is too low to continue with it. In addition, the controls don’t look right: the negative control shows a smear while the positive control does not show anything. Conclusion: New attempts of DNA amplification are needed, new set of primers should be used and the results should be compared. | |||||||||||||||||||||
RAD102: New pcr with T7 promoter and T7 terminator and gel electrophoresis with eluted and the new DNA samples.Background: New attempt of the PCR reaction with old and new set of primers | |||||||||||||||||||||
3rd of June 2024 Participants:
Experimental:PCR:
Gel Electrophoresis:
| |||||||||||||||||||||
6th of June 2024 Participants:
Experimental:Electrophoresis:
Results and Discussion:Figure: 1st DNA ladder, 2nd negative control, 3rd positive, 4th reaction, 5th eluted DNA (RAD101), 6st another DNA ladder. 03/06/24 There was no band in the positive control as not the correct primer was used. The negative control had a smear. The reaction had a smear and a small band. The eluted DNA was not amplified, thus there was a small band as expected. Figure 2. Left to right: 1st DNA ladder, p2 eluted, p1 eluted, positive control, p1 cdna, p2 negative control, p2 cdna, p1 negative and at last again a ladder. 06/06/2024 Again very big smears, molecular ladder was not good visible, only good well was the positive control. For some unknown reason, these samples have not run far on the gel, so the results are difficult to interpret. Advice:Column purifies sample 4 and 5. Another suggestion is to restart and make all samples again. Samples 4 and 5 are the 2 samples with good bands on the right site of the gel (you can also count the slots/bands from left to right and then you will see that those are the 4th and 5th). Conclusion:We decided to remove the smeared DNA by the means of purification in the next experiment, RAD103. The insight after the purification will provide understanding of such behavior of the DNA. | |||||||||||||||||||||
RAD103: PCR purification of the DNA product from experiment RAD102, and its analysis.Background: The smeared DNA from the experiment RAD102 was decided to be removed by the means of purification in the next experiment. The insight after the purification will provide understanding of such behavior of the DNA. | |||||||||||||||||||||
10th of June 2024 Participants:
Experimental:Purification of PCR product:
Used protocol:PCR of purified PCR product: 3 samples were prepared: positive control (not the purified PCR ‘+’ control) and 2 samples of plasmid cDNA from the purified PCR product (see, 10/06/2024 purification of PCR product).
Making of the gel & electrophoresis: Agarose gel:
| |||||||||||||||||||||
28th of June 2024 Participants:
Experimental:Gel electrophoresis of 2 cdna:
NOTE: This note describes how the gel is made on this day. On the same day when the gel has been made the PCR products of RAD103 (5th part) have been loaded onto the gel. Later the PCR product of RAD104 (1st part) has been loaded on the same gel. Results of that can be seen in RAD104 (3rd part). Results and Discussion:Figure 3. 28/06/24 In the picture above we can see that our results still have smears which is not what we want, the next time we will perform PCR and look at the product on a gel we will use new primers in the hope we can fix the issue with the smears. Nothing has happened which could potentially influence the results. Indication of 4 slots (from left to right): gene ladder, negative control P2, positive control, cDNA with primers P1. The 4th slot contains a very slight band indicating the amount of amplified DNA was very scarce. if the picture is zoomed in, a slight band at around 7.5 kB can be seen. Conclusion:DNA amplification was unsuccessful as no clear band is visible in the expected range (ca 8000 bp). The smears likely indicate bonding between the primers and the formation of large structures of various sizes. Another primer combination should be tried. | |||||||||||||||||||||
RAD104: Analysis of FVIII from RAD103 and GFP DNA PCR & analysisBackground: We made combinations of the different Factor 8 primers using both old and new primers and we also wanted to perform PCR on GFP DNA by using the standard GFP primers. So there are no new primers for the GFP but only the ones that are always used. | |||||||||||||||||||||
28th of June 2024 Participants:
Experimental:GFP; new pcr with new primers:
| |||||||||||||||||||||
1st of July 2024 Participants:
Experimental:Gel electrophoresis:
Results and Discussion:Figure 1. Gel electrophoresis As seen in the picture above we again got smears on our gel. Another strange anomaly is that in the GFP well (second to last) we could see a very vague band all the way at the bottom of the gel and a very vague band somewhere at the top. This of course shouldn’t be happening since the gel should show 1 band somewhere low in the gel. For the 5 Factor 8 samples the same could have gone wrong as with all the other PCR reactions that have been performed (we still don’t know what it is), however it is very strange that also the GFP (second to last slot) has also failed to give a good result. We have used the primers that normally work well so it can’t be the primers fault, this might indicate that something is wrong with the procedure which causes the smears. Conclusion:We will have to meetup with Frank in order to discuss these results. The reliability of our results is probably good enough, however for the 4th sample the pipetting went a bit wrong which led to the loss of some of the sample (it disappeared in the gel) furthermore during the transfer of the gel from the gel electrophoresis machine onto the UV machine, the gel broke. We reassembled it and we could still see things like the molecular ladder therefore we think it hasn’t impacted our results by a lot. After consultation with Frank, it was decided to try the multiplying F8 DNA with a different method (RAD107) and to try again with the GFP because it had worked before. | |||||||||||||||||||||
RAD105: GFP DNA - second attemptBackground: The purpose of the experiment is to produce a placeholder GFP mRNA for model experiments. PCR mix was made following “PCR procedure Radboud-University Team”. Since primers are already known, the negative and positive controls are not going to be used. Materials: For the production of the GFP mRNA 20ng/ul PUC-18 GFP template was used. The primers to be used were the following: Forward primer used: EF-eGFP fwd for cloning, Tm = 65.2 C. Reverse primer used: EF-eGFP rvd for cloning, Tm = 65.3 C. Both primers were deluted to 10 uM in the previous experiment - RAD104. The gel electrophoresis procedure in the reference indicated to use 10x TBE (also for the buffer) 100 ml and 1mg agarose. However, our method will use 0.5x TBE (also for the buffer) 100 ml and 0.7 agarose gel. It is safe to dispose of this buffer in the sink, but the gel needs to be thrown out in the waste. Calculations: Amounts of GFP template to be added: 2.5 ng (needed DNA)/ 20 ng/ul (given concentration) = 0.125 ul - to add. Amounts of DNA poly template to be added: (need to be calculated, but were over-added compared to “PCR procedure Radboud-University Team”). | |||||||||||||||||||||
3rd of July 2024 Participants:
Experimental:PCR:
Gel electrophoresis:
Results and Discussion:Figure 1. 1st well: DNA ladder (Kate); 2nd well: GFP sample 1 (Lea); 3rd well: GFP sample 2 (Lea); 4th well: GFP sample 3 (Kate); 5th well: DNA ladder (Thijmen). A GFP mRNA was correctly received at the 1000 bp region (see the ladder). However, the spot is very dim, so this means that not many DNA was produced. Conclusion:The decision was made to redo the PCR to make more DNA. Then, 3 to 4 reactions of 100 ug with 20 ng of the template per 100 ul will need to be prepared, and they will be run for 25 PCR cycles. After consultation with Frank, it was decided to try the multiplying F8 DNA with a different method (RAD107) and to try again with the GFP because it had worked before. | |||||||||||||||||||||
RAD106: GFP DNA - Upscaled PCR reactionBackground: The purpose of the experiment is to increase of the amounts of production of GFP mRNA for model experiments compared to the experiment attempt RAD105. PCR mix was made following “PCR procedure Radboud-University Team”. Since primers are already known, the negative and positive controls are not going to be used. Materials: For the production of the GFP mRNA 20ng/ul PUC-18 GFP template was used. The primers to be used were the following: Forward primer used: EF-eGFP fwd for cloning, Tm = 65.2 C. Reverse primer used: EF-eGFP rvd for cloning, Tm = 65.3 C. Both primers were deluted to 10 uM in the previous experiment - RAD104. The gel electrophoresis procedure in the reference indicated to use 10x TBE (also for the buffer) 100 ml and 1mg agarose. However, our method will use 0.5x TBE (also for the buffer) 100 ml and 0.7 agarose gel. It is safe to dispose of this buffer in the sink, but the gel needs to be thrown out in the waste. Calculations: The amount of mastermix was increased 4x: 333 μL MilliQ water, 45 μL 10x PCR buffer, 45 μL 2 mM dNTPs (10 mM each dATP, dTTP, dGTP. dCTP), 9 μL 10 μM forward primer, 9 μL 10 μM reverse primer, 9 μL Pfu polymerase (2ul per 100 g) 450 μL final volume. | |||||||||||||||||||||
3rd of July 2024 Participants:
Experimental:PCR:
Gel electrophoresis:
Results and Discussion:Figure 1. 1st well: DNA ladder (Kate); 2nd well: GFP sample 1 (Lea); 3rd well: GFP sample 2 (Lea); 4th well: GFP sample 3 (Kate); 5th well: DNA ladder (Thijmen). A GFP mRNA was correctly received at the 1000 bp region (see the ladder). However, the spot is very dim, so this means that not many DNA was produced. Conclusion:The decision was made to redo the PCR to make more DNA. Then, 3 to 4 reactions of 100 ug with 20 ng of the template per 100 ul will need to be prepared, and they will be run for 25 PCR cycles. After consultation with Frank, it was decided to try the multiplying F8 DNA with a different method (RAD107) and to try again with the GFP because it had worked before. | |||||||||||||||||||||
4th of July 2024 Participants:
Experimental:Gel electrophoresis:
Gel electrophoresis 2:
Results and Discussion:Figure 1. 1st gel of our product: DNA ladder, SPILL, normal, normal, X and another DNA ladder. Figure 2. 2nd gel of our product: DNA ladder, 2, 2, SPIL, 1. In the first gell, no DNA was seen, but we wanted to check the presence of DNA, and added the ethidium bromide to one PCR sample. Since the flask shined, this indicated that there is some DNA. Thus, the new PCR was prepared, as well as the samples were loaded onto a new gel again for second analysis. Still, in the second gel no results were seen which indicated that the DNA was indeed not present. Thus, the new experiment was decided to be conducted - RAD108. Conclusion:No DNA apparently was present in the sample. It is likely that an error was made and one of the ingredients was not added correctly. This meant that the procedure would need to be repeated. | |||||||||||||||||||||
RAD108: GFP mRNA - increase the amount 2Background: The purpose of the experiment is to upscale production of GFP mRNA for model experiments compared to the experiment attempt RAD106. PCR mix was made following “PCR procedure Radboud-University Team”. Since primers are already known, the negative and positive controls are not going to be used. Materials: For the production of the GFP mRNA 20ng/ul PUC-18 GFP template was used. The primers to be used were the following: Forward primer used: EF-eGFP fwd for cloning, Tm = 65.2 C. Reverse primer used: EF-eGFP rvd for cloning, Tm = 65.3 C. Both primers were diluted to 10 uM in the previous experiment - RAD104. The gel electrophoresis procedure in the reference indicated to use 10x TBE (also for the buffer) 100 ml and 1 mg agarose. However, our method will use 0.5x TBE (also for the buffer) 100 ml and 0.7 agarose gel. It is safe to dispose of this buffer in the sink, but the gel needs to be thrown out in the waste. Calculations: The amount of mastermix was increased 4x: 333 μL MilliQ water, 45 μL 10x PCR buffer, 45 μL 2 mM dNTPs (10 mM each dATP, dTTP, dGTP. dCTP), 9 μL 10 μM forward primer, 9 μL 10 μM reverse primer, 9 μL Pfu polymerase (2ul per 100 g) 450 μL final volume. | |||||||||||||||||||||
3rd of July 2024 - 4th of July 2024 Participants:
Experimental:PCR:
Gel electrophoresis:
The samples were loaded in the gel run on 110V for 50 min. Results and Discussion:Figure 1. Gel electrophoresis (0.7% w/v agarose) of the PCR samples All samples showed a clear band at 1000kb, where it is expected. Conclusion:It was decided to continue with the purification. | |||||||||||||||||||||
RAD109: PCR purification of the GFP DNA product from experiment RAD108, and its analysis.Background: The DNA from the experiment RAD108 had smears, so it was decided to purify it. For the PCR purification, the protocol QIA PCR purification was followed. (“QIAquick® PCR Purification Kit”). | |||||||||||||||||||||
4th of July 2024 Participants:
Experimental:Purification of PCR product:
Gel electrophoresis of purified product:
Results and Discussion:Figure 1. Agarose gel of purified product: ladder; sample. The result of the Gel is good - a little smear at the top probably occurred due to too much DNA concentration. The band is around 1000 bp, which is where you would expect EGFP. Figure 2. Analysis with nanodrop: Measured samples of the GFP cDNA showed a concentration of 60.2 ng/ul. Conclusion:The pure GFP cDNA sample of 185 ul with concentration 60.2 ng/ul was received. The application of it is to produce mRNA for the further experiments and testing of the vesicles. |
DNA Amplification via Bacterial Plasmids
03/07/24 - 08/07/24
RAD107: Transformed bacteria colony preparationBackground: The purpose of the experiment is to make the transfected bacteria with an inserted FVIII vector plasmid. The bacteria are cultured on antibiotic full media, so only the ones that have absorbed this plasmid can survive. The bacterial cultures used are Top10 and XL1Blue (both E.coli strains optimized for plasmid amplification) |
3rd of July 2024 - 4th of July 2024 Participants:
Experimental:Procedure:
Conclusion: These successful bacteria synthesis allows for further FVIII isolation and production (RAD110) |
RAD110: Miniprep of cp FVIII DNA and digestionBackground: Extraction of the DNA samples from the bacteria cultures, prepared in the RAD107 experiment: Top10 and XL1 Blue. Plasmid used is linked here. |
5th of July 2024 Participants:
Experimental:Cultures used:
Procedure:
Digestion:
Linearisation:
Analysis:
Results and Discussion:Figure 1. EcoRI digest The EcoRI digestion showed 4 bands, as expected. Figure 2. XhoI digest. The Xhol digestion shows one band, as expected. Figure 3. Expected results scheme Conclusion: FVIII pcDNA was extracted from the bacterial cultures Top10 and XLBlue. The gel analysis of enzymatically linearized DNA confirmed its proper structure. The further steps of the FVIII DNA processing is the linearization of more plasmid, and then purifying it. This DNA then should be transcribed to FVIII mRNA. |
RAD111: Large Xho1 digestionBackground: Scaled up linearisation of plasmids for the use in in vitro transcription. The XL1Blue plasmids are used because they were isolated in a higher concentration. The Xho1 digestion will linearise the plasmid right after the coding sequence, allowing for run off transcription. |
8th of July 2024 Participants:
Experimental:Cultures used:
Procedure:
Results and Discussion:The digested plasmids show clear bands at the length where we expected them. Conclusion: A large amount of linear FVIII pcDNA was produced and purified. This can now be used to perform in vitro transcription and produce FVIII mRNA. |
IVT and mRNA Purification
09/07/24 - 30/08/24
RAD112: IVT of the GFP and Factor VIII RNABackground: The "In vitro synthesis of RNA using T7 RNA polymerase” protocol was used to translate mRNA from the cpFVIII DNA samples received in the experiment RAD110, as well as the GFP DNA received in the experiment RAD109. | ||||||||||||
9th of July 2024 Participants:
Experimental:
Results and Discussion:Figure 1. Agarose gel electrophoresis of IVT samples. To prevent waste, we use the same agarose gel for multiple experiments. The crossed out lanes are from a previous experiment. It is weird that 1, 2 and 4 with 2uL T7 did not show a lot of transcription while 3 seems to have a lot, because they should practically be the same. Overall, the reaction seems to work better with 4uL T7. The FVIII RNA was expected to be longer than 7000 instead of 1200. This could be the result of RNA degradation or self splicing, but it could also be because of the properties of the gel and because RNA is not linear. In addition, the GFP RNA did not work out that well in both cases. it could have something to do with the template. maybe the calculations on the amount of template needed was incorrect. → I (Lea) recalculated the amount of template needed and I did receive a different outcome: 45 ng/20uL. This is a 15ng difference from what was used in this experiment. Conclusion: Experiment needs to be repeated with proposed changes:
| ||||||||||||
RAD113: 2nd IVT iterationBackground: Mutated T7 (polymerase) is the T7 used last time, now we are also testing the wild type. We are redoing the EGFP with the new calculation and trying an RNAse inhibitor to try and stop RNA degradation. Calculations:
| ||||||||||||
10th of July 2024 Participants:
Experimental:IVT:
Gel electrophoresis:
Results and Discussion:Figure 1. Agarose gel electrophoresis of IVT samples. To prevent waste, we use the same agarose gel for multiple experiments. The crossed out lanes are from a previous experiment. During the pipetting of the sample 3 the pipette tip fell off, which may be the cause of the absent band. Samples 4 and 5 seem pure with only minor smearing. Samples 2 and 7 have a significant smear, which could be perhaps resolved by using denaturing conditions that would eliminate the RNA’s autocatalytic activity. Conclusion: Adding an RNase inhibitor improves the outcome of IVT. Sample analysis on denaturing gel should be carried out in order to eliminate autocatalytic activity of the RNA molecule. GFP samples give more clear bands on the native gel than the factor VIII samples. | ||||||||||||
RAD114: IVT of GFP + FVIIIBackground: For the IVT, the In vitro synthesis of RNA using T7 RNA polymerase protocol was used. For IVT we need between 5 and 50 nM of dsDNA. We want 10 nM, for FVIII linearised plasmid, 75ng of DNA is needed for 20uL reaction, for GFP it is 26ng. The concentrations of the FVIII DNA was close enough that 1uL could be taken from the tube. The GFP DNA was diluted 1:1 to a concentration of 30ng/uL and 1uL was used from that (from RAD112). Calculations:
| ||||||||||||
15th of July 2024 Participants:
Experimental:
Results and Discussion:Figure 1. The samples with inhibitors show more clearly visible bands on the gel. There are significant smears on the gel. Further purification and modification is required in order to obtain a clearer result. There is only one visible band per sample. Conclusion: The procedure used in this experiment is effective at synthesizing and analyzing mrna. Rnase inhibitors should always be used for better results. | ||||||||||||
RAD115: IVT. RNA synthesis scale up of FVIII & GFP | ||||||||||||
17th of July 2024 Participants:
Experimental:
Results and Discussion:The bands all show up at the same hight, while a significant difference in length was expected. the first 3 samples were made with GFP template DNA and the last 2 with F8, so the first 3 should be way lower compared to the last 2. Although we were quite confident in our pipetting, this could be due to a pipetting mistake while adding the template DNA or when putting the samples on the gel. RiboLock RNase inhibitor should always be addded in this procedure. Conclusion: Only GFP mRNA was rececived & analysed on the gel. Samples 1*, 2*, 3*, 4*, 5*. Next steps: purification with phenol chlorophorm extraction. optimise for GFP, then move on to FVIII. | ||||||||||||
RAD116: 1st trial RNA purification using phenol:chloroformBackground: protocol based on: RNA Clean-up by phenol:chloroform v2. With the mRNA purification, we are trying to get samples which would only contain the mRNA that we want, this will be done by following a protocol which will lead to the removal of any IVT ‘ingredients’ that are present in the sample. By removing these and keeping the mRNA in tact, we will get a pure mRNA for further experiments. | ||||||||||||
18th of July 2024 Participants:
Experimental:
22nd of July 2024 Participants:
the gel showed nothing. possibly because the sample was too diluted. Results and Discussion:
Endo or exonuclease which might affect the mRNA.
Conclusion:The purification procedure does not seem to yield the desired results. Procedure optimisation is required prior to further attempts. | ||||||||||||
RAD117: 2nd trial purificationBackground: Further attempts of the purification of the IVT samples | ||||||||||||
22nd of July 2024 Participants:
Experimental:
Discussion:The problem is most likely not caused by a too dilute sample, but it could be the result of the buffer being multiple days old. It might have picked up RNases that have degraded the sample while in the gel. 23rd of July 2024 Participants:
Discussion:The problems are not caused by a diluted sample or by an old buffer. It might be a more fundamental problem with the purification method. Conclusion: Optimization of the purification procedure is needed before the continuation of the experiments as the current procedure seems to yield suboptimal results. | ||||||||||||
RAD118: repeat upscale IVT FVIII RNABackground: Preparation of the new F8 mRNA as the previous samples have been stored in the freezer for a long time | ||||||||||||
22nd of July 2024 Participants:
Experimental:
23rd of July 2024 Participants:
Results and Discussion:The gel showed no bands, likely indicating either a complete samples’ degradation or a mistake made during the purification. The latter idea is supported by the seemingly negative RNA concentration in the sample Conclusion: New mRNA samples have to be prepared, care should be taken to avoid any potential mistakes during IVT setup or mRNA purification. | ||||||||||||
RAD119: 5-minute gel testBackground: Previous experiments with purification led to results that were not favourable. This checkup is done in order to check whether there truly is no mRNA. | ||||||||||||
29th of July 2024 Participants:
Experimental:The purified GFP mRNA sample was taken out of the fridge after which it was quickly vortexed. In order to have enough sample to be able to pipet it 5ul of miliQ water was added to the sample. After this 5uL of the purified mRNA GFP sample was added to an epp and 2ul of loading dye was added to the same epp. This epp was then vortexed to mix the 2 ingredients. Next, the sample + loading dye mixture was pipetted into the gel after which the gel was run for 5 minutes at 110 volts. ResultFigure 1. Attempt 1 gel of purified GFP mRNA. 5 minute gel check. DiscussionAs can be seen on the photo, even after 5 minutes of running the gel there is no band visible. This would indicate that the current purification method is not working properly. A new purification method is used in RAD120. Conclusion: Purification method should be revised, and the new method repeated and performed. | ||||||||||||
RAD120: Purification of GFP mRNA trial 3Background: GFP samples 2* and 3* from the experiment RAD115. | ||||||||||||
29th of July 2024 Participants:
Note: all the materials that were used during the purification (like epps and pipet points) were sterile and all the work was done with gloves. This all will ensure a RNase free environment.
29th of July 2024 Participants:
The purified GFP mRNA sample named Pure GFP 29/07/2024 was taken. After this 5uL of the purified GFP sample was added to an epp and 2ul of loading dye was added to the same epp. This epp was then vortexed to mix the 2 ingredients. Next, the sample + loading dye mixture was pipetted into the gel after which the gel was run for 5 minutes at 110 volts. 30th of July 2024 Participants:
The purified GFP mRNA sample named Pure GFP 29/07/2024 was taken. After this 5uL of the purified GFP sample was added to an epp containing 2ul of loading dye. This epp was then vortexed to mix the 2 ingredients. Next, the gel was loaded. In the first well 5 ul of a molecular ladder was pipetted and in the second well 5 ul of the sample + loading dye was pipetted. After this the gel was run for 50 minutes at 110 volts. 30th of July 2024 Participants:
A new gel was made by using the following protocol:
After the new gel was made the sample was prepared. The purified GFP mRNA sample named Pure GFP 29/07/2024 was taken. After this 5uL of the purified GFP sample was added to an epp containing 2ul of loading dye. This epp was then vortexed to mix the 2 ingredients. Next, the gel was loaded. In the first well 5 ul of a molecular ladder was pipetted and in the second well 5 ul of the sample + loading dye was pipetted. After this the gel was run for 50 minutes at 110 volts. Results and Discussion:We hope that by replacing the isopropanol with ethanol and by working with sterile equipment that the mRNA will survive the purification step and that we will receive pure GFP mRNA. In order to check if the purification really worked we have to run the samples on a gel. Figure 1. Attempt 2 gel of purified mRNA. 5 minute gel check. Date: 29-07-2024 As can be seen on the figure 1, there is mRNA present in the sample. In order to check if the RNA is pure and if it is the right RNA a complete gel electrophoresis must be done including a molecular ladder. Figure 2. Gel electrophoresis of pure GFP RNA sample part 1. Date: 30-07-2024 As you can see on the photo the sample looks pure as far as we can see. However both the sample and the ladder are very vague. This could be due to an error, a too low concentration (which would be bad in the case of the sample) or that the gel is too old. It was hypothesized that the gel is too old since it has been made 1 or 2 weeks prior. Next step is to refresh the gel and rerun the sample. | ||||||||||||
RAD121: Purification of mRNA trial 4, scaling upABackground: Same phenol-chloroform procedure as in the RAD120 extraction with larger quantities of GFP and FVIII mRNA. | ||||||||||||
1st of August 2024 Participants:
Experimental:
Results and Discussion:Figure 1. Gel electrophoresis of the purified samples A small band is visible for the GFP, however, with a large smear above and below it. Factor 8 did not appear on the gel, however, as it was taken from an old epp, it may have been degraded prior to purification. The likely explanation for the weak gel signal is the unsterile conditions of the pipette tips and epps as they have not been sterilized after previous use, or the old buffer used to run the gel. Conclusion: More proper sterilization of the equipment is needed prior to every purification procedure. More mRNA of both GFP and factor 8 should be produced. | ||||||||||||
RAD122: Making more FVIII & GFP mRNABackground:We try to make some more mRNA for both GFP and F8. The F8 has gone bad, and more GFP mRNA was decided to be produced. | ||||||||||||
1st of August 2024 Participants:
Experimental:We labeled epps 1 to 4 and we used the same protocol as was described in RAD114. Only difference is that we used the WT polymerase instead of the mutated polymerase and also the amount of DNA added to the samples is different due to a lower DNA concentration.
Results and Discussion:Figure 1. Gel electrophoresis of the samples obtained from the IVT As can be seen, the gel shows no bands, likely indicating a mistake during the preparation of the IVT mixture. Conclusion: Since there likely was a mistake in the IVT setup, the experiment should be repeated. | ||||||||||||
RAD123: 2* and 3* sample purificationBackground: We try to purify a previously (week or 2/3 ago) made sample, to purify it we used the updated purification method described in RAD120, but we used different amounts of certain ingredients. We used 35 ul of sample (both pipetted in different epps), 35 ul of the phenol chloroform or something (real name is in RAD120), 75ul of ethanol (both 96% and 70%) and last but not least 50 ul of the Mili Q water outside that we followed the normal protocol. | ||||||||||||
2nd of August 2024 Participants:
Experimental:2* and 3* sample for purification. Same protocol as for RAD116 In both cases, 35 ul of sample and 35 ul phenol/chloroform/isoamyl alcohol mixture were initially combined, 75 uL ethanol were used and in the last step the sample was dissolved in 50 uL Milli-Q water. Results and Discussion:Figure 1. Gel electrophoresis of the purified samples As can be seen, only 2 small bands corresponding to the eGFP mRNA are visible, both containing a smear; and no bands are observed that would correspond to factor 8. The likely explanation for that would be mRNA degradation as a result of using non-sterile equipment when handling the samples. Conclusion: The mRNA purification was unsuccessful and should be repeated with sterile equipment and solutions. | ||||||||||||
RAD124: IVT of factor 8Background: The factor 8 from previous entries has degraded so a new batch has to be prepared. DNA stored at -19.7 C is used. Procedure for “RAD 114” is used.
| ||||||||||||
13th of August 2024 Participants:
Experimental:
ResultsDNA concentration of the samples in ng/uL
Discussion:It seems that the machine showed the phenol contamination, as well as no mRNA present in the samples. This leads us to the conclusion that we will not test these mRNAs on the gel, since no mRNA was left. Conclusion: The experiment needs to be repeated in RAD126. | ||||||||||||
RAD125: Purification of the samples 1, 2, 3, 4 from RAD124 and 4*, 5* from RAD115; 1, 2, 5 from RAD114; F8 mRNA (unkown); unlabellled sample (7000 ng/ul [c])Background: In order to conclusively analyse the GFP and FVIII mrna samples from experiments RAD114 , RAD115, and RAD124, the samples will be first purified using phenol chloroform extraction, following the procedure from experiment RAD120. | ||||||||||||
9th of July 2024 Participants:
Experimental:
Results and Discussion:Figure 1. Agarose gel electrophoresis of IVT samples. To prevent waste, we use the same agarose gel for multiple experiments. The crossed out lanes are from a previous experiment. It is weird that 1, 2 and 4 with 2uL T7 did not show a lot of transcription while 3 seems to have a lot, because they should practically be the same. Overall, the reaction seems to work better with 4uL T7. The FVIII RNA was expected to be longer than 7000 instead of 1200. This could be the result of RNA degradation or self splicing, but it could also be because of the properties of the gel and because RNA is not linear. In addition, the GFP RNA did not work out that well in both cases. it could have something to do with the template. maybe the calculations on the amount of template needed was incorrect. → I (Lea) recalculated the amount of template needed and I did receive a different outcome: 45 ng/20uL. This is a 15ng difference from what was used in this experiment. Conclusion: Experiment needs to be repeated with proposed changes:
| ||||||||||||
RAD126: Attempt 2. Purification of the samples 1, 2, 3, 4 from RAD124 and 4*, 5* from RAD115; 1, 2, 5 from RAD114; F8 mRNA (unknown); unlabellled sample (7000 ng/ul [c])Background: Experiment RAD125 failed. We need to modify the procedure, and add a step of chloroform purification to prevent phenol contamination. | ||||||||||||
13th of August 2024 Participants:
Experimental:
Results and Discussion:Figure 1. Gel of all the samples except for 5* GFP, FVIII 1, FVIII 2. No samples were seen. Since the procedure was repeated twice, the likely reason for no visible bands on the gel is mRNA degradation → I (Lea) recalculated the amount of template needed and I did receive a different outcome: 45 ng/20uL. This is a 15ng difference from what was used in this experiment. Conclusion: The new samples need to be made in the following experiment. | ||||||||||||
RAD127: Synthesis of factor 8 and GFP mRNABackground: The quality of the RNA samples previously made is under question, so a new batch is produced following the procedure from RAD 114 | ||||||||||||
14th of August 2024 Participants:
Experimental:Mastermix prepared:
NOTE: 120ul left after experiment and labelled MM Samples prepared in following manner added from right to left:
Results and Discussion:RNA concentration in the samples (ng/ul)
Low ratio of A230/A260 indicates contamination of the samples, hence sample purification is needed in the following experiment. Conclusion: RNA samples show relatively high levels of contamination. Next step is to purify & analyze this RNA. | ||||||||||||
RAD128: Purification of GFP and FVIII mRNA. Samples from RAD127Background: It was understood that 3 volumes of ethanol for 100 ul aqueous phase and 10 ul 3 mol sodium acetate need to be added since we have increased the amount of aqueous phase from previous experiments. For the step with 70%, it doesn’t matter how much ethanol you add because it is used to collect the remaining contamination. The gel without formaldehyde - the regular agarose gel (TBE, EtBr) can be | ||||||||||||
16th of August 2024 Participants:
Experimental:
Participants:
Participants:
| ||||||||||||
20th of August 2024 Participants:
The samples A-L now are analyzed. All phases taken were aqueous.
Experimental:
Results and Discussion:Figure 1. Agarose gel electrophoresis of IVT samples. To prevent waste, we use the same agarose gel for multiple experiments. The crossed out lanes are from a previous experiment. It is weird that 1, 2 and 4 with 2uL T7 did not show a lot of transcription while 3 seems to have a lot, because they should practically be the same. Overall, the reaction seems to work better with 4uL T7. The FVIII RNA was expected to be longer than 7000 instead of 1200. This could be the result of RNA degradation or self splicing, but it could also be because of the properties of the gel and because RNA is not linear. In addition, the GFP RNA did not work out that well in both cases. it could have something to do with the template. maybe the calculations on the amount of template needed was incorrect. → I (Lea) recalculated the amount of template needed and I did receive a different outcome: 45 ng/20uL. This is a 15ng difference from what was used in this experiment. Conclusion: Experiment needs to be repeated with proposed changes:
Participants:
Denaturing agarose gel was prepared:
| ||||||||||||
21st of August 2024 Participants:
Samples from Friday were noted with 5 at the end of the letter (A, E, H, J, L, F) (ex. A5) Samples from Tuesday 20.08 were labeled with 2d.
| ||||||||||||
21st of August 2024 Participants:
Note for agarose gel: Instead of 0,7 g of agarose, there was 0,82 g of agarose added. This will probably not influence the results but in the future it should be 0,7 g of agarose. Instead of the normal 0,5x TBE buffer we used in this gel a 1x TBE buffer. This was done by mixing 10 ml of 10x TBE with 90 ml of demi-water.
Another gel was prepared: all amounts halved: 45 ml demi H20 + 5 ml TBE 10x. + 2.5 ul EtBr. This gel was loaded left to right: H5, I2d, F5, K2d, E5, I2d*, J2d*, A5, C2d*, H2d*, B2d, D2d*, F2d. (Figure 6) | ||||||||||||
23rd of August 2024 Participants:
The new gel was prepared: 100 ml + 0.7 g agarose was heated in the microwave, but the solution boiled, and ~ 25 ml went out. I only took 50 from the solution. 2.5 ul EtBr was added and continuously swirled before added to the tray. The gel was poured in the tray, and cooled for 50 min. The samples were prepared for loading: 9ul of loading die (2x LB RNA) + 1 ul of sample (14 samples in total) Incubated for 10 min at 70 C. Results and Discussion:Labeling: A, B - F8 1, C, D - F8 2, E, F - F8 3, G, H - F8 4; I, J, K, L - GFP Figure 1. Data lost. Bright - GFP, Dim - FVIII. Most probably: A, E, F, H, J, L Figure 2. Mutated poly FVIII, wild poly FVIII, GFP test Figure 1. Loading order: 1st row: F5 (F8) A5 (F8) L5 (eGFP) H5 (F8) E5 (F8) J5 (eGFP) eGFP (test); 2nd row: B2d (F8) L2d (GFP) J2d (GFP) F2d (F8) K2d (GFP) E2d (F8) Nanodrop: Sample L and E (showed empty) from Tuesday had errors and also I* and G* had errors. K4 has very low concentration. F2d had very high concentration, but didn’t show on the gel. Friday (5):
Tuesday: Figure 2. Concentrations tuesday 1 Figure 3. Concentrations tuesday 2 The nanodrop showed the concentrations of following samples to be faulty: L2d, E2d, I2d* and G2d*. E2d got empty. The analysis was repeated. They were remeasured with nanodrop: L2d 28.2 ng/ul, others did not give any results (probably, since they had no RNA (the faulty ones due to mislabelling), or due to the presence of ethanol - quick evaporation (probably, ethanol is also present in the L2d). Figure 4. Masses of the RNAs and their concentrations The following total masses of RNAs were received. It is weird that F5 has very big concentration, but is not visible on the gel. Same for the B2d, F2d. The gel results are hampered by Ethidium Bromide, and were repeated, but it can be concluded that the samples loaded seem to show the presence of valid compounds, so with that assumption experiments are decided to be continued with these samples. Figure 5. Test GFP on the cut gel The new gel made was too thick, so the cutting procedure was done to make it thin, which was successful. The gel made afterwards was made by the techniques described in the background. Figure 6. This gel was loaded left to right: H5, I2d, F5, K2d, E5, I2d*, J2d*, A5, C2d*, H2d*, B2d, D2d*, F2d. The GFP mRNA has left the gel, so the gel should be run for less than 50 min (blues line in the middle) Figure 7. F8 mRNA G2d sample visible, row 10. Visible: 1 (band), 3, kinda 4, 8, 10, 12; Loading order: Frank’s F8; A2d; A5; B2d; C2d; D2d*; E5; F4; F5; G2d; H2d; H5; I2d; Frank GFP Only F8 G2d was seen, and no GFP - probably ran away. Conclusion:The FVIII mRNA (G2d) was received in the sufficient amount for further modification - capping and tailing, 7.5 ul, 1428 ng/ul, 10.71 ug. Next steps:
| ||||||||||||
RAD131: IVT and Purification of F8 and GFP samplesABackground: Preparation of new GFP and factor 8 mRNA, purification and analysis on 0.7% and 2% agarose gel | ||||||||||||
26th of August 2024 Participants:
IVT was performed by following the following protocol:
What DNA each tube contains (I have to check the freezer for this):
| ||||||||||||
27th of August 2024 Participants:
This day I wanted to start with purification of the samples from 26-08-2024, but due to phenol oxidation and lack of time, it couldn’t be done. What was done today is as follows:
| ||||||||||||
28th of August 2024 Participants:
This day the purification was performed and analyzed. The purification was done in the following way:
After the purification was done the samples were loaded on a gel which was made the day before. To load the samples the following protocol was used:
Further notes: Sample A probably has a bit less volume because of a pipetting error (shouldn’t be more then 1 ul). During the loading the wells looked a bit weird from sample E onwards, it was like there was an air bubble in there. Results and Discussion:As can be seen, the gel looks empty which could have multiple reasons, to be sure what the actual reason is that it looks this way Frank is consulted the next day. Frank said that the gel looks very blue while it should look more purple/pink. The reason why it is blue is probably because the gel doesn’t contain any ethidium bromide. Conclusion: The gel looks empty because of a lack of ethidium bromide in the gel. For future work it is advised to make a new gel and rerun the samples. During the gel running the samples have also been nano-dropped. For this 1,5 ul of each sample was put in the nanodrop machine. Results and Discussion:Purely based on the nanodrop results the samples look very promising, they have high concentrations with a good clean curve and no sign of contamination. Conclusion: Samples look good in the nanodrop, only the gel will tell us whether the samples are truly good. For future await gel results. | ||||||||||||
29th of August 2024 Participants:
By the advice of Frank a new gel was prepared today and also a ‘gel making station’ was setup in lab 3 (from 30-08-24 in lab 4). The gel was made in the following way:
Results and Discussion:Most of the samples that were loaded didn’t show up on the gel. We did see a clear band for sample C and the modified GFP. We also see some very vague smears at samples B, D and E. We think that there is again something wrong with the gel because the gel results and the nanodrop results do not match. What is also weird is that our positive sample didn’t show up which could be both a fault in the gel or a fault in the positive sample. Conclusion: After consulting with Frank, the most likely reason why the gel doesn’t show anything and the nanodrop shows high concentrations is that the mRNA probably is degraded into little mRNA pieces, which would then run out of the 0,7% agarose gel but will still show a high concentration on the nanodrop. The modified GFP looks good and can be used for vesicle experiments!! In the future, it is recommended to rerun the bad samples (so not sample C and modified GFP) on a 2% agarose gel to see whether there is degraded mRNA. Also, the modified GFP can be used in future experiments, the modified F8 can not be used until further notice. | ||||||||||||
30th of August 2024 Participants:
Frank advised to make a 2% agarose gel so that’s what was done as follows:
Results and Discussion:If you closely observe the gel you can see that the first loaded gel (sample A) has something in it. This might be the degraded mRNA of which Frank spoke. This is of course not certain but it is an indication. Conclusion: We decided to load all the bad samples and run them for a longer period of time to see if we could spot more of these possible fragmented pieces of mRNA.
Results and Discussion:We can see in the gel that sample G looks very good, it looks bright and pure which is weird given that it didn’t show up like this on the previous gel. Why this is we don’t know and we should consult Frank about this. Furthermore, we can see that samples A, D and J are mainly a big vague smear which could indicate that these samples contain degraded mRNA fragments. Last but not least we see that the positive control sample shows up in this gel as a little pure line. This is good but also weird because why does it show up here and not on the previous gel? This is again something to discuss with Frank. Conclusion: Sample G could be a good purified sample which can be used for capping and tailing but it must first be discussed with Frank because why didn’t it show up on the previous gel? As for samples A, D and J we can say that these are degraded mRNA fragments but just to check show Frank. Also, ask Frank why the positive sample shows up on this gel but not the previous one. I think these are the best steps to take for the next lab day. |
mRNA Purification and Modification
26/08/24 - 11/09/24
RAD129: Cap-0 synthesis using Vaccinia Capping Enzyme (NEB #M2080)Background: We used the following capping protocol for the following. Post-transcriptional capping and Cap-1 methylation Post-transcriptional capping is often performed using the mRNA capping enzyme from Vaccinia virus or Faustovirus. This enzyme complex converts the 5´-triphosphate ends of in vitro transcripts to m7G-cap (Cap-0) required for efficient protein translation in eukaryotes. The Fausto Virus capping enzyme (NEB #M2081) comprises three enzymatic activities (RNA triphosphatase, guanylyltransferase, guanine N7-methyltransferase) that are necessary for the formation of the complete Cap-0 structure, m7Gppp5´N, using GTP and the methyl donor S-adenosylmethionine. As an added option, the inclusion of the mRNA Cap 2´ O-Methyltransferase (NEB #M0366) in the same reaction results in formation of the Cap-1 structure (m7Gppp5´Nm), a natural modification in many eukaryotic mRNAs responsible for evading cellular innate immune response against foreign RNA. This enzyme-based capping approach results in a high proportion of capped message, and it is easily scalable. The resulting capped RNA can be further modified by poly(A) addition before final purification. This protocol is designed to cap up to 10 µg of RNA (100 nt or larger) in a 20 µl reaction. Reaction size can be scaled up, as needed. The system provides enough reagents to perform 40 reactions at the 10 µg RNA/20 µl reaction scale. Samples:
Aliquots of 2ul of SAM. +30 ul milliq = 32 ul of SAM (2 mmol) (Because SAM degrades very easily and for every sample, new aliquot was used) For GFP: 13.3 ug = 1.33 times more than specified in protocol, so the volumes of materials for the GFP sample were increased. | ||||||||||||||||
26th of August 2024 Participants:
Experimental:
Purification of the capped samples:
Results and Discussion:As far as we can tell the capping was done successfully since we followed the provided protocol, however, we can’t check right now if it has been successful since we will only place the samples on the gel when the whole RNA modification is done. Tomorrow we will continue with the tailing so for now the samples are stored in the freezer (-20 degrees Celcius). Conclusion: The RNA capping has been done successfully, so we can proceed with tailing the samples tomorrow. | ||||||||||||||||
RAD130: A-tailing using E. coli Poly(A) PolymeraseBackground: The tailing protocol that we used is found here. The poly(A) tail confers stability to the mRNA and enhances translation efficiency. The poly(A) tail can be encoded in the DNA template by using an appropriately tailed PCR primer, or it can be added to the RNA by enzymatic treatment with E. coli Poly(A) Polymerase (NEB #M0276). The length of the added tail can be adjusted by titrating the Poly(A) Polymerase in the reaction (Figure 6). The importance of the A-tail is demonstrated by transfection of untailed vs. tailed mRNA. When luciferase activity from cells transfected with equimolar amounts of tailed or untailed mRNAs were compared, a significant enhancement of translation efficiency was evident (Figure 6). HiScribe T7 ARCA mRNA Synthesis Kit (with tailing) (NEB #E2060) includes E. coli Poly(A) Polymerase, and enables a streamlined workflow for the enzymatic tailing of co-transcriptionally capped RNA. [https://www.neb.com/en/tools-and-resources/feature-articles/minding-your-caps-and-tails ] | ||||||||||||||||
27th of July 2024 Participants:
GFP sample has 13.3 ug = 1.33 times more than required in protocol, so the volumes of materials for the GFP sample were increased. To make 1X E. coli Poly(A) Polymerase (5X) Reaction Buffer: 4ul E. coli Poly(A) Polymerase + 16 ul water =20 ul 1x E. coli Poly(A) Polymerase Reaction Buffer Add the following components in the order specified:
Participants:
Note: in step 5 only 70% ethanol was added instead of 100%. The 30% water might have dissolved the rna. The samples were centrifuged at 30000G for 5 min again. 100 ul 100% ethanol was added and samples were centrifuged for 5 min at 25000G. Participants:
Results and Discussion:Figure 1. gel electrophoresis of modified mRNA (well 11: modified F8 mRNA 1, 12: modified F8 mRNA 2, 13: modified GFP mRNA, 14: positive control) samples to the left belong to RAD131. Only the modified GFP mRNA is visible on this gel. Suggesting that capping and tailing of this RNA was successful, but that of the F8 RNA was not. This could be because the F8 RNA was already less stable. Conclusion: The modification was successful on the GFP RNA, but the F8 RNA should be repeated. To get around our problems with purifying the F8 RNA, Frank tried our method. | ||||||||||||||||
RAD132: Capping and tailing of GFP (sample G) and F8 mRNABackground: In this experiment, a second attempt at tailing and capping is done. In the last experiments (RAD129-RAD130), a small amount of GFP RNA was successfully modified. modification of F8 RNA was not yet successful, but we received a large amount of purified F8 RNA from our supervisor Frank which might have a better quality and will hopefully stay intact during the tailing and capping. | ||||||||||||||||
4th of September 2024 Participants:
Capping: a new 2 mM SAM dilution was prepared: 2uL (32mM)SAM + 30uL MilliQ. Sample prep:
purification: (same protocol as in RAD129)
| ||||||||||||||||
5th of September 2024 Participants:
tailing: (same protocol as RAD130)
| ||||||||||||||||
6th of September 2024 Participants:
analysis: The two samples were analyzed on a 0.7% 50 min 110V Results and Discussion:Figure 1. After capping and tailing the gel showed no stain Even though the capping went well (pellet was seen), the tailing went bad (no pellet, even though the pellet should become even bigger). This might be due to absence of Mg2+ in the tailing enzyme. Conclusion: The capping procedure from the experiment RAD 132 worked out. However, after the tailing procedure no product was seen. The gel showed no stain. The Mg2+ will be added to the tailing enzyme. | ||||||||||||||||
RAD133: Capping and tailing of GFP (sample G) and F8 mRNABackground: The capping procedure from the experiment RAD 132 worked out. However, after the tailing procedure no product was seen. The gel showed no stain. No MnCl2 was added in the last experiment, this would have inhibited the poly(A) formation. However, it does not explain the lack of yield. In this experiment, the procedure is repeated with minor adjustments and with | ||||||||||||||||
11th of September 2024 Participants:
Experimental:
Samples were incubated at 65C for 5 min Samples were cooled on ice for 5 min The following components were added in the order specified:
Incubate at 37°C for 30 minutes Purification: (same protocol as in RAD129) For each sample:
| ||||||||||||||||
13th of September 2024 Participants:
Tailing: For every sample: the following components were added:
NOTE: potential small pipetting error in F8-1 with adding PAP Incubated at 37C for 30 min. Purification: Analysis:
Results and Discussion:
Nanodrop results:
Conclusion: The concentration of RNA was too low to be seen on the gel, but due to the time constraints, it was decided to move on with this RNA. |
Ionizable Lipids Preparation
31/05/24
RAD201: Preparation of 246 ionizable lipidsBackground: The ionizable lipids are synthesized by an epoxide ring-opening reaction: The lipid nanoparticle comprising an ionizable lipid significantly affects the characteristics of the LNPs. They can increase or decrease the drug encapsulation efficiency; create more or less uniformly-sized particles; and improve the effectiveness of the drug delivery into the hepatocytes or LSEC cells. Ionizable lipids are crucial for LNP preparation, and they provide effective mRNA encapsulation, as well as safe LNP delivery in the body. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691360/ Equipment:
Chemicals/Solutions
Safety aspects and precautions:
|
9th of July 2024 Participants:
Experimental:
Results and Discussion:Yield: crude yellow oil, 1.018 g (pure), 4.224 g (total - not pure), 0.00451 mol, 94.5%; 1H-NMR (300; CDCl3, RT), ppm: 0.9 (A, CH3, m), 1.3 (B, CH2, m), 2.15 (acetone), 2.5 (C, NC, m), 3.5 (D, COH, m), 5.25 (DCM), 7.3 (CDCl3); 13C-NMR (300; CDCl3, RT), ppm: 15 (A, CH3, s), 25-35 (B, CH2, many s), 30 (acetone), 50-60 (C, CN, many s), 60-70 (D, COH, many s), 78 (CDCl3); COSY-NMR (300; CDCl3, RT), ppm: 1 to 1.5, 2.5 to 3.5, 1.5 to 3.5; HSQC-NMR (300; CDCl3, RT), ppm: 3.75 (H) - 70 (C); 2.5 (H) - 60 (C); 1.5 (H) - 25~35 (C); 1(H) - 10 (C). The results of the analysis show that the 1H-NMR, 13C-NMR, COSY-NMR, and HSQC-NMR have the needed compound. However, COSY-NMR did not show the specific bond found between the B and D region. This was considered a possible mistake in the machine, and the needed structure was confirmed by the HSQC-NMR and LC-MS. Figure 1. 1H-NMR of ionizable lipids in CDCl3 at RT. Figure 2. Reference NMR spectra from the [1]. Figure 3. 13C-NMR of ionizable lipids in CDCl3 at RT. Figure 4. COSY- NMR of ionizable lipids in CDCl3 at RT. Conclusion: The compound was synthesized correctly, with high purity and high enough yield for the next experiments. References:
|
Trial Yeast mRNA LNPs
26/06/24 - 16/09/24
RAD112: IVT of the GFP and Factor VIII RNABackground:To understand how the formulation of the LNPs go, an experiment without using LNPs at first must be conducted. LNP preparation followed by the “LNP procedure”. Ionizable lipids were formulated in RAD201. Cholesterol, PBS buffer, and compounds to make citrate buffer 10mM pH4 are present. The compounds DOPC & DOPE - 50 ul of 50 mg/ml; DSPE PEG - 2000 - 50 ul of 50 mg/ml have been received from the Zainab Javed. mRNA should be stable in citrate at 4 pH [1]. At high pH, mRNA is not comfortable. Yeast mRNA used: torula yeast RNA. Methods: Ethanol injection - provides low mRNA encapsulation efficiency, but is cheap and fast. [2] DLS - size and Z-potential Calculations: 1 attempt: 250 uL liposomes, 10 ul DOPE, 1 - 2 ul charged lipids, 1uL chol - 7 day (half of these for LNPs) | ||||||||||||||||||
26th of August 2024 Participants:
Experimental:
| ||||||||||||||||||
27th of August 2024 Participants:
The next day they were resuspended in 50 ul of ethanol, concentration - 50 mg/ml for DOPC and DOPE, and 10 mg/ml of PEG. | ||||||||||||||||||
28th of August 2024 Participants:
| ||||||||||||||||||
29th of August 2024 Participants:
I weighed 1.5 mg and added it to 70 ml of 10 mM, 4 pH citrate solution. Lipids were sonicated for 5 min at RT.
I added the mixture of lipids 1 ml to 3 ml mRNA in a citrate solution with a syringe. I stirred them vigorously for 10 min. I stored LNP samples, citrate, and cholesterol in RT, the rest of components at -20C.
| ||||||||||||||||||
30th of August 2024 Participants:
Experimental:
| ||||||||||||||||||
3rd of September 2024 Participants:
| ||||||||||||||||||
5th of September 2024 Participants:
Results and Discussion:Figure 1. DLS. Size measurement of LNPs1 in the Liposome material mode; Dispersant PBS: Average; 3 single measurements. Figure 2. DLS. Z-potential measurement of LNPs1 in the Liposome material mode; Dispersant PBS: Average; 3 single measurements. Cholesterol affects the size of the lipids, maybe this is why bigger than 100. Figure 3. DLS. Size measurement of LNPs1 in the PEG2000 material mode; Dispersant PBS: Average; 3 single measurements. Figure 4. DLS. Z-potential measurement of LNPs1 in the PEG2000 material mode; Dispersant PBS The results above show that our LNP size is around the desirable 100 nm. However, it is a bit more, it is assumed that it is due to the ethanol injection methods uncertainty, so this could be improved with microfluidic mixing. The Z-potential showed weird results. This is assumed to be related to the high acidity of the sample due to its improper purification - always add the sample only to the highest mark in the membrane chamber, and the rest is buffer. This is probably the reason why some ions and salts did not go away. Solution of purified LNPs1 turned out purple after several days. This is assumed due to a highly acidic environment, which also proves the above point.The LNPs were not sonicated, and this is why they showed bigger size. The purification method was changed, so it is strange that the LNPs still showed high pH. It potentially might be due to not sufficient dialysis steps (only one hour). Conclusion: LNPs have turned their color to purple, which suggests that either some reaction with LNPs occurred during their storage, or some contamination happened. LNPs were stored in RT, now they will be stored at 4C. LNPs were taken up by syringe during the dialysis analysis. Now, an aliquot will be taken for the analysis, since there is a suspicion that metal from the syringe might have colored the sample. Always add the sample only to the highest mark in the membrane chamber, and the rest is a buffer. Also, samples should be purified for more than 1 hour. (Potentially, the PBS buffer should be not 10x, but 1x). The Z-potential was most probably affected by purification. Finally, sonication should always be performed before the DLS measurement. Advice: always sonicate LNPs before analysis/usage, since they agglomerate References:
| ||||||||||||||||||
RAD203: Formulation of LNPs with Torula Yeast mRNA inside, second attemptBackground: The LNPs from the RAD202 experiment have turned out the needed size, but have changed color, and showed weird Z-potential. The goal of RAD203 is to figure out why this might be happening, as well as trying to introduce a new analysis method - encapsulation analysis using fluorescence spectroscopy of LNPs. The protocol: LNP encapsulation efficiency. Yeast mRNA used: torula yeast RNA. Methods:
Safety: SYBR® Gold - Mutagenic; dissolved in buffer - keep in fridge, -4C (months); regular - in freezer, -20C. | ||||||||||||||||||
3rd of September 2024 Participants:
Experimental:Compounds were mixed together in the same way as RAD202. NOTE: Yeast mRNA in citrate solution was left out of the fridge overnight. | ||||||||||||||||||
9th of September 2024 Participants:
Figure1. NOTE: Upon storage at -4C, and not interacting with DLS metallic syringe, the LNPs have not turned purplish! Encapsulation efficiency analysis Add 0.24 ul of LNPs (stock - 147.5 g/ml) to 10 ml of solvent (PBS 1x) -> 0.0036 g/ml LNPs Yeast mRNA (was stored at -20C) was warmed to liquid. The following delusion scheme was prepared: 6 samples dissolve each 2-fold:
| ||||||||||||||||||
11th of July 2024 Participants:
DLS analysis
Figure 0. Purple color change observed after DLS. Reason Unknown. Potentially - metal on the needle/ processes that happen within a DLS machine. Another aliquot of LNPs was taken, sonicated and analyzed on DLS (D). Results and Discussion:Figure 1. Figure 1. DLS before sonification. Size measurement of LNPs3 in the PEG2000 material mode; Dispersant PBS Figure 2. DLS before sonification. Z-potential measurement of LNPs2 in the PEG2000 material mode; Dispersant PBS Figure 3. DLS after sonication. Size measurement of LNPs2 in the PEG2000 material mode; Dispersant PBS; DLS after sonication (top 3). Z-potential measurement of LNPs2 in the PEG2000 material mode; Dispersant PBS (middle one); DLS after sonication. Size measurement of LNPs2 in the Liposomes material mode; Dispersant PBS (bottom 3) After DSL LNPs turn purple for unknown reasons. In the 1st measurement RAD203 I did sonicate LNPs (helps agglomerate them), so I measured them again after sonication, and received too big of sizes of LNPs which proved that something changes them after DLS and purple color is the consequence. Figure 4. Setup of the DLS The LNPs in the first DLS measurement were not sonicated, which gave results with a bigger size. They were then sonicated after the measurement, and taken for a second DLS measurement. After the first DLS measurement, the LNPs have turned purplish, and gave weird results in the second DLS measurement. Encapsulation efficiency Analysis was not successful, potentially due to the procedure performed in a rush. The background noise value was for some reason showing values bigger than the measured values, which of course can not be the case. Conclusion: The LNPs hich are measured for the second time after DLS show weird change to purple color, and potentially form conglomerates, since the size values of LNPs in the second DLS increased significantly. Z potential still behaves weirdly. It is assumed that the following behavior might be due to the low pH in the LNP solution which makes ionizable lipids gain positive charge, so in the next experiment, 1xPBS with higher pH (~7) will be used to check if Z will change. Encapsulation efficiency analysis will be performed more carefully in the following experiments, more time will be provided for the procedure to prevent potential mistakes. | ||||||||||||||||||
RAD204: Formulation of LNPs with Yeast mRNA inside, second attemptBackground: The purplish color behavior was related to the DLS - procedure. However, the Z-potential from the experiment RAD 202-203 can still not be changed. This is why, in this experiment PBS1x will be used instead of PBS10x to see if this affects the Z-potential. Yeast mRNA used: torula yeast RNA. | ||||||||||||||||||
13th of September 2024 Participants:
Experimental:
| ||||||||||||||||||
16th of September 2024 Participants:
DLS analysis. Results and Discussion:Figure 1. Agarose gel electrophoresis of IVT samples. To prevent waste, we use the same agarose gel for multiple experiments. The crossed out lanes are from a previous experiment. Figure 2. DLS Z-potential measurement of LNPs204 in the Liposome material mode; Dispersant PBS In this experiment, LNPs were sonicated before the measurement, so the size of theirs is as expected - around 100 nm [1]. However, the Z-potential was still showing weird numbers - high positive which means that particles are very dispersed in the mixture, but for some reason positively charged. It is assumed that these particles are behaving this way because the LNP composition is different from [1]. PEG-2000 is used, and no mannose PEG is present. It is assumed that the mannose must provide LNPs with some sort of shielding effect, negating their positive charge. Conclusion: The Z potential seems to be high due to high dispersion of the LNP particles, and high which is a difference from the reference [1] possibly due to different LNP composition. This means that PBSx1 or PBSx10 do not affect the Z, but the properties of particles. References:
|
F8 and GFP mRNA LNPs
16/09/24 - 27/09/24
Formulation of LNPs with GFP mRNA or F8 mRNA inside, first attemptBackground: The following samples from RAD133 will be inserted in the LNPs: 5xFV GFP (or F GFP in 133RAD), GFP 4 (4 samples in LNPs and not-inserted); F8 3, 5xFV F81 (4 samples in LNPs and not-inserted).
Also control GFP samples will be borrowed from Martin Emmaneel, CODE: 3C1B - T10e mRNA AN_MEI_06d, and encapsulated. Methods:
| ||||||||||||||||||
16th of July 2024 Participants:
Experimental:Lipids were sonicated for 5 min at RT, and formulated in LNPs with following proportion:
For 5xFV GFP, the stock was diluted by 96.11865483 | ||||||||||||||||||
17th of July 2024 Participants:
The following set-up was used: Hot plate for f8 got heated to 33C for 5 min, then switched off. LNPs were added not while mixing, but mixing started right away. 10 minutes. Then, 7th sample - no-mRNA LNPs were prepared separately, and lipids were added correctly - during the spinning. | ||||||||||||||||||
18th of July 2024 Participants:
LNPs were purified with a dialysis machine. 1h, 3290xg, RT 2x times in PBS10x buffer. | ||||||||||||||||||
18th of July 2024 Participants:
TEM
| ||||||||||||||||||
19th of July 2024 Participants:
DLS was conducted. Results and Discussion:It is important to note that the samples with mRNA inside were prepared wrong - lipids were added BEFORE the mixing, and fast, and not during the mixing. This might affect the results of the mRNA LNP complexes. Figure 1. DLS size measurement of LNPs205 LNPs with no mRNA in the Liposome material mode; Dispersant PBS Figure 2. DLS Z-potential measurement of LNPs205 LNPs with no mRNA in the Liposome material mode; Dispersant PBS Figure 3. DLS size measurement of LNPs205 LNPs with GFP control mRNA in the Liposome material mode; Dispersant PBS Figure 4. DLS Z-potential measurement of LNPs205 LNPs with GFP control mRNA in the Liposome material mode; Dispersant PBS In the figures above, you can see that the size of the LNPs is off. Both, for LNPs with no mRNA and with mRNA inside. Even though, when the mixing was done correctly for the LNPs with no mRNA, the size improved, but is still bigger, since no sonification was performed (the concentration of lipids for the no-mRNA was high). This could indicate that upon injection of ethanol, the ethanol and aqueous phase mix, and do not provide for the right mixing between mRNA and lipids, leading to lipid clusters suspended in the liquid. This is observed only now, and not in previous experiments, since the lipid concentration now is very low, and this affects the method results a lot. It is recommended to use the pulsification method or microfluidics device to prevent this in the future. TEM Figure 1. LNPs with no mRNA under TEM Figure 2. LNPs with mRNAs under TEM - none present Conclusion: It is crucial to add the lipids DURING the mixing step, and not before, since it prevents from forming LNP-mRNA complex. LNPs almost do not form with the ethanol injection method at very low concentration. It is recommended to use higher concentration of lipids, and implement a pulsification method or microfluidics device to prevent this in the future. The TEM does not show any LNPs with mRNA, but shows the LNPs without. It also shows that encapsulation is complex, and might lead to no results if some aspect is not done correctly (in this case - mixing, and low concentration).
|
HEK Cells
09/07/24 - 30/08/24
RAD301: Transfection of mRNA in HEK cellsBackground: eGFP mRNA made by us and control eGFP mRNA was transfected into HEK cells to check the functionality of our synthesized mRNA. In this transfection, RNA is diluted with buffer and formed into liposomes using a transfection reagent, this is mixed with HEK cells and incubated overnight. It was planned to also transfect LNPs containing eGFP mRNA, but this was postponed due to an experimental error in synthesizing these LNPs. | ||||||||||||||||
19th of September 2024 Participants:
Experimental:
Results and Discussion:The 3CB control shows visible expression indicating transfection was successful. However, the expression of the control was expected to be higher. Low expression can be explained by the fact that the cells were not very healthy when the transfection was performed. The expression of our synthesized mRNA is a lot lower, but some cells expressing GFP can be found - like the one indicated by the red arrow. The negative control is empty. Conclusion:We produced functional mRNA. However, the expression is not optimal. From this we can conclude that our method for synthesizing mRNA works, but could be improved. Due to the low expression of our mRNA, it might be beneficial to use the 3CB GFP mRNA to test the efficiency of the LNPs. | ||||||||||||||||
RAD302: Transfection of mRNA in HEK cells, attempt 2Background: It will be attempted to insert mRNA from experiment RAD133 and LNPs from experiment RAD206. The following scheme of transfection will be implemented: mRNAs used: GFP 1, GFP2, F8 1, 5x FV F8 2, control GFP; LNPs used: LNPs with no mRNA, GFP1 LNPs, GFP2 LNPs, F8 1 LNPs, 5xFV F8 2 LNPs, GFP cont LNPs; one slot with just cells, one slot with method for mRNA transfection. LNP transfection was done by using the following procedure: HEK Cell experiment. No Western blot was done. Control GFP samples will be borrowed from Martin Emmaneel, CODE: 3C1B - T10e mRNA AN_MEI_06d. | ||||||||||||||||
24th of September 2024 Participants:
Results and Discussion:Figure 1. The control GFP mRNA is expressed Figure 2. Our mRNA samples and LNPs (also the one with control GFP) with mRNA, no GFP detected (same picture for all) Figure 3. Trans picture of cells with the LNPs inside (same picture for all) Figure 4. Cells without fluorescence - survived Only the sample with control GFP was expressed. This implies that the mRNA samples are nonfunctional (GFP 1, which was slightly expressed in RAD301, was not visible here, potentially due to denaturation). Since control was expressed by regular transfection, and not with LNPs, the LNP synthesis procedure in the moment is not efficient. SDS-PAGE gel was considered to be unnecessary for analysis of F8 protein presence, since if there was no expression of control GFP, than yes, but since there is no expression of the experiment with GFP whose RNA also looked better from the start, I think it is a waste of time and resources. In the final effort, I would put my money on getting the transfection both with JetMessenger ánd LNPs to work before analyzing protein extracts of cells. Conclusion:Combining the results from the RAD206, RAD133, and RAD203, it can be said that the reason for the following transcription result is a combination of the results from all 3 factors: HEK cells are used instead of the cells used in the reference [1] - HeLa or LSEC cells, different lipid composition was used: instead of DSPE-PEG 2000, C16-PEG ceramide (PEG-lipid) and DSPE-PEG-mannose lipids were used, and the mRNA experiments provided very low yield of functionable mRNA. This resulted in no transfection fluorescence of just GFP mRNA samples (except for the control one), since the mRNA from RAD133 also was not visible on the gel, and in no transfection fluorescence of GFP in LNPs. However, the LNP procedure was also not efficient - very little amount of LNPs produced in combination with different compounds used for production. It is advised to make more mRNA samples after consultation on the current results, procedure and storage should be revised. Different cell cultures should be used: either HeLa or LSEC cell lines. Also, for LNPs, it is recommended to use higher concentration of lipids, and implement a pulsification method or microfluidics device to prevent low yields of LNPs in the future. It is also recommended to purchase more expensive compounds for LNP formulation, as in the referenced article [1]: instead of DSPE-PEG 2000 - C16-PEG ceramide (PEG-lipid) and DSPE-PEG-mannose lipid which might provide for the better targeting during transfection. References:
|